[go: up one dir, main page]

IL143604A0 - Dispersable concentrate for the delivery of cyclosporin - Google Patents

Dispersable concentrate for the delivery of cyclosporin

Info

Publication number
IL143604A0
IL143604A0 IL14360499A IL14360499A IL143604A0 IL 143604 A0 IL143604 A0 IL 143604A0 IL 14360499 A IL14360499 A IL 14360499A IL 14360499 A IL14360499 A IL 14360499A IL 143604 A0 IL143604 A0 IL 143604A0
Authority
IL
Israel
Prior art keywords
surfactant
formulation
cyclosporin
less
dispersable
Prior art date
Application number
IL14360499A
Original Assignee
Dexcel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexcel Ltd filed Critical Dexcel Ltd
Publication of IL143604A0 publication Critical patent/IL143604A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

A formulation for the administration of a cyclosporin. This formulation features a hydrophilic solvent which is characterized by being a lower alkyl ester of hydroxyalkanoic acid; and a surfactant, preferably a combination of a surfactant with a high HLB (hydrophilic/lipophilic balance) of at least about 8 and a surfactant with a low HLB of less than about 5. Other ingredients are optional, such as a fatty acid ester such as tricaprin, a phospholipid, and an ethoxylated fat such as Cremophor or another similar substance. Optionally, the ethoxylated fat is substituted for the surfactant. The preferred particle size of the resultant formulation is less than about 100 nm, more preferably less than about 60 nm, and most preferably from about 5 nm to about 50 nm. The formulation of the present invention is characterized by having high bioavailability.
IL14360499A 1998-12-30 1999-12-30 Dispersable concentrate for the delivery of cyclosporin IL143604A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22337898A 1998-12-30 1998-12-30
PCT/IL1999/000710 WO2000040219A1 (en) 1998-12-30 1999-12-30 Dispersible concentrate for the delivery of cyclosporin

Publications (1)

Publication Number Publication Date
IL143604A0 true IL143604A0 (en) 2002-04-21

Family

ID=22836258

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14360499A IL143604A0 (en) 1998-12-30 1999-12-30 Dispersable concentrate for the delivery of cyclosporin

Country Status (12)

Country Link
US (1) US7026290B1 (en)
EP (1) EP1154759B1 (en)
JP (1) JP2002534370A (en)
AT (1) ATE404172T1 (en)
AU (1) AU769429C (en)
CA (1) CA2358448C (en)
DE (1) DE69939335D1 (en)
DK (1) DK1154759T3 (en)
IL (1) IL143604A0 (en)
NZ (1) NZ512599A (en)
PT (1) PT1154759E (en)
WO (1) WO2000040219A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US7026290B1 (en) 1998-12-30 2006-04-11 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosprin
GB9912476D0 (en) * 1999-05-28 1999-07-28 Novartis Ag Organic compounds
AU2006201100B2 (en) * 1999-09-21 2009-09-24 Jagotec Ag Surface modified particulate compositions of biologically active substances
AU7984200A (en) * 1999-09-21 2001-04-24 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7919113B2 (en) * 1999-12-30 2011-04-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dispersible concentrate lipospheres for delivery of active agents
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
OA12619A (en) 2001-06-21 2006-06-12 Pfizer Prod Inc Self-emulsifying formulations of cholesteryl estertransfer protein inhibitors.
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
DE102006051512A1 (en) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmaceutical drug compositions with cyclosporin
DE102006050026A1 (en) * 2006-10-13 2008-04-17 Bio Mac- Privatinstitut für medizinische und zahnmedizinische Forschung, Entwicklung und Diagnostik GmbH Use of lactic acid compounds as tumor necrosis factor-alpha blocker, e.g. for suppressing immune system, for prophylaxis and/or treatment of autoimmune diseases and/or inflammatory diseases, preferably rheumatoid arthritis, spondylitis
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
GB2451811A (en) * 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
CA2701482C (en) * 2007-10-08 2018-10-23 Lux Biosciences, Inc. Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
ES2537385T3 (en) 2009-06-09 2015-06-08 Aurinia Pharmaceuticals Inc. Topical supply systems for ophthalmic use
KR101586791B1 (en) * 2012-12-28 2016-01-19 주식회사 종근당 Sustained-release lipid pre-concentrate of GnRH analogues and pharmaceutical composition comprising the same
US20150352176A1 (en) * 2014-06-06 2015-12-10 Newport Research, Inc. Oil-free and fat-free aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117118A (en) 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
FI65914C (en) 1978-03-07 1984-08-10 Sandoz Ag FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A
US4215199A (en) 1978-06-05 1980-07-29 Sandoz Ltd. Antibiotic production
EP0034567B1 (en) 1980-02-14 1984-11-07 Sandoz Ag A method for the total synthesis of cyclosporins and novel cyclosporins
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US4861580A (en) 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5154930A (en) 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
KR880012221A (en) 1987-04-13 1988-11-26 사노 가즈오 Pharmaceutical compositions containing esters or amides as active ingredients
DE3884470T2 (en) 1987-06-17 1994-03-10 Sandoz Ag Cyclosporins and their use as medicines.
US5756450A (en) 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US4994267A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
WO1991014463A1 (en) 1990-03-28 1991-10-03 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US4814168A (en) 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
GB8809616D0 (en) 1988-04-22 1988-05-25 Cancer Res Campaign Tech Further improvements relating to drug delivery systems
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (en) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 Pharmaceutical composition containing cyclosporin
SE8804164A0 (en) 1988-11-17 1990-05-18 Per Prisell Pharmaceutical preparation
HU201577B (en) 1988-12-20 1990-11-28 Gyogyszerkutato Intezet Process for producing cyclosporin antibiotics
DE69013189T2 (en) 1989-03-15 1995-05-11 Merck & Co Inc Method for producing an immunosuppressive substance (demethimmunomycin) by using a strain mutant of a microorganism.
US5272068A (en) 1989-03-15 1993-12-21 Merck & Co., Inc. Process for producing immunosuppressant agent L-683942 by fermentation
CA2013755C (en) 1989-04-05 1993-11-30 Simon Benita Medicinal emulsions
WO1991007171A1 (en) 1989-11-13 1991-05-30 Nova Pharmaceutical Corporation Lipospheres for controlled delivery of substances
IE904098A1 (en) 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5227165A (en) 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5178866A (en) 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
ES2095926T5 (en) 1990-11-02 2001-02-16 Novartis Ag CYCLOSPORINS
HU208491B (en) 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
CA2101777A1 (en) 1991-01-25 1992-07-26 Toshio Goto Process for producing cyclosporin a and/or c
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5171217A (en) 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
ATE127528T1 (en) 1991-04-06 1995-09-15 Dresden Arzneimittel METHOD FOR THE FERMENTATIVE PRODUCTION AND ISOLATION OF CYCLOSPORIN A AND NEW CYCLOSPORIN-PRODUCING STRAINS.
US5683714A (en) 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
ES2088160T3 (en) 1991-04-19 1996-08-01 Nexstar Pharmaceuticals Inc CHEMICAL FORMULATION AND PROCESS.
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ATE217526T1 (en) 1992-02-18 2002-06-15 Pharmos Corp DRY COMPOSITIONS FOR PRODUCING EMULSIONS IN THE SUBMICRON RANGE
IL101007A (en) 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
US5637317A (en) 1992-05-18 1997-06-10 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
US5529785A (en) 1993-05-12 1996-06-25 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
HU213553B (en) 1992-05-25 1997-07-28 Biogal Gyogyszergyar Process for isolating of cyclosporin-a
IT1260505B (en) 1992-06-01 1996-04-09 Poli Ind Chimica Spa ORAL PHARMACEUTICAL SYSTEMS WITH DELAYED DELIVERY FOR THE SPECIFIC RELEASE IN THE COLON
US5759566A (en) 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
SK277092A3 (en) 1992-09-07 1996-08-07 Galena As Medicaments with n-methylated cyclic undecapeptides
PT589843E (en) 1992-09-25 2002-04-29 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
IT1256386B (en) 1992-11-13 1995-12-04 Luigi Boltri PHARMACEUTICAL COMPOSITIONS INCLUDING A DRUG, A CROSS-LINKED POLYMERIC SUBSTANCE, AN OIL AND A SURFACTIVE AGENT
FI92334C (en) 1992-12-30 1994-10-25 Leiras Oy Process for producing cyclosporins and new Tolypocladium strain useful in the process
HU223045B1 (en) 1993-04-20 2004-03-01 Hexal Ag. Patch containing estrogen or progestagen hormone
DE4338086A1 (en) 1993-11-08 1995-05-11 Dietl Hans Cyclosporin (e) containing pharmaceutical preparation for oral administration and process for their preparation
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
GB2278780B (en) 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (en) 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
US5639474A (en) 1993-07-01 1997-06-17 Hanmi Pharm. Ind., Ltd. Cyclosporin soft capsule composition
DE4322826A1 (en) 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmaceutical preparation
ES2068762B1 (en) 1993-07-21 1995-12-01 Lipotec Sa A NEW PHARMACEUTICAL PREPARATION TO IMPROVE THE BIOAVAILABILITY OF DRUGS OF DIFFICULT ABSORPTION AND PROCEDURE FOR THEIR OBTAINING.
PT649651E (en) 1993-09-28 2001-03-30 Scherer Gmbh R P PREPARATION OF SOFT GELATINE CAPSULES
DE10199039I2 (en) 1993-10-22 2008-08-07 Hexal Ag Ind 25 PHARMACEUTICAL COMPOSITION WITH CYCLOSPORIN A, A VITAMIN DERIVATIVE AND AN EMULSIFIER
IL107471A (en) 1993-11-02 1997-09-30 Yissum Res Dev Co Pharmaceutical preparation comprising a self- emulsifying formulation and process for its production
DE4340781C3 (en) 1993-11-30 2000-01-27 Novartis Ag Liquid preparations containing cyclosporin and process for their preparation
DE4402867C1 (en) 1994-01-31 1995-06-14 Rentschler Arzneimittel Liposome(s) contg. encapsulated protein for pharmaceutical or cosmetic use
DK0797432T3 (en) * 1994-02-04 2001-09-03 Scotia Lipidteknik Ab The oil-in-water emulsions
US5891846A (en) 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
KR0146671B1 (en) 1994-02-25 1998-08-17 김충환 Cyclosporin-containing powder composition
GB9405304D0 (en) 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5430021A (en) 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5651980A (en) 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles
ES2137516T3 (en) 1994-06-01 1999-12-16 Yuhan Corp COMPOSITION BASED ON CYCLOSPORINE AND ITS MANUFACTURING PROCEDURE.
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
EP0697214A1 (en) 1994-07-19 1996-02-21 Vestar, Inc. Liposomal cyclosporin pharmaceutical formulations
KR100304324B1 (en) 1994-10-13 2001-11-22 김용규 Method for manufacturing cyclosporine a
KR0126610B1 (en) 1994-10-18 1997-12-29 김충환 Producing method of cyclosporina by cell fusioned microorganism
MY129435A (en) 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
AU715165B2 (en) 1994-11-03 2000-01-20 Novartis Ag Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
US5603951A (en) 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
DE4440337A1 (en) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmaceutical nanosuspensions for drug application as systems with increased saturation solubility and dissolution rate
HU215966B (en) 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Oral multiple emulsion-preconcentrate containing cyclosporin
DE4446470A1 (en) 1994-12-23 1996-06-27 Basf Ag Process for the production of dividable tablets
KR0167613B1 (en) 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 Cyclosporine-containing soft capsule composition
EP0725076B1 (en) 1995-02-01 2001-06-06 National Research Development Corporation of India A process for the preparation of cyclosporin A from tolypocladium species
US5573783A (en) 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
FI102758B1 (en) 1995-03-03 1999-02-15 Santen Oy Process for producing pure cyclosporine form
IE75744B1 (en) 1995-04-03 1997-09-24 Elan Corp Plc Controlled release biodegradable micro- and nanospheres containing cyclosporin
WO1996033697A1 (en) 1995-04-24 1996-10-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
EP0825849A1 (en) 1995-05-19 1998-03-04 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
US5716928A (en) 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5656287A (en) 1995-06-07 1997-08-12 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
US5616595A (en) 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
US5665386A (en) 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5827822A (en) 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
SI9620014A (en) 1995-08-25 1998-04-30 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
EP0760237A1 (en) 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
KR0180334B1 (en) 1995-09-21 1999-03-20 김윤 Drug messenger using el-2l-2 micelle and method for sealing drug to it
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
DE19549852B4 (en) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin containing preparations
DE19545043A1 (en) 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmaceutical preparations for oral use and process for their preparation
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
CZ288631B6 (en) 1996-01-18 2001-08-15 Galena, A. S. Therapeutic preparations containing cyclosporin
KR970064620A (en) * 1996-03-05 1997-10-13 임성기 Cyclosporin-containing external-use pharmaceutical composition
DE19611094C2 (en) 1996-03-21 1999-06-17 Dresden Arzneimittel Process for the purification of cyclosporin A and / or related cyclosporins from a cyclosporin-containing crude extract using chromatographic processes using silica gel as the adsorbent
IL117773A (en) 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5660858A (en) 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
IT1282733B1 (en) 1996-05-20 1998-03-31 Flarer S A PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORIN AND A CARRIER INCLUDING AT LEAST ONE ALPHA-GLYCEROPHOSPHORIC ACID ESTER
US5747330A (en) 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
US5709797A (en) 1996-06-05 1998-01-20 Poli Industria Chimica S.P.A. Method of isolating cyclosporins
US5958876A (en) 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
CA2240705C (en) 1996-06-19 2007-07-31 Novartis Ag Cyclosporin-containing soft capsule preparations
US5958378A (en) 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
KR980008239A (en) 1996-07-26 1998-04-30 김충환 Cyclosporin-containing pharmaceutical composition
US5798333A (en) 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
NZ314060A (en) 1997-01-13 1997-08-22 Bernard Charles Sherman Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s)
EP1331002A3 (en) 1997-01-30 2004-01-14 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin A
CA2283780A1 (en) 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
SI0969856T1 (en) 1997-03-12 2005-06-30 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
HU223054B1 (en) 1997-03-25 2004-03-01 BIOGAL Gyógyszergyár Rt. Purification process for producing high purity ciklosporin a
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US5891845A (en) 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
US6063762A (en) 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US6028067A (en) 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
ID25908A (en) * 1998-03-06 2000-11-09 Novartis Ag EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES
JP2002513750A (en) 1998-05-07 2002-05-14 エラン コーポレーシヨン ピーエルシー Solvent / co-solvent free microemulsion and emulsion pre-concentrate drug delivery system
FR2780061B1 (en) 1998-06-22 2001-09-07 Rhone Poulenc Rorer Sa NOVEL PROCESS FOR THE PREPARATION OF CYCLOSPORIN DERIVATIVES
WO2000003753A2 (en) 1998-07-14 2000-01-27 Em Industries, Inc. Microdisperse drug delivery systems
WO2000006120A1 (en) 1998-07-31 2000-02-10 Korea Institute Of Science And Technology Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
JP2002525311A (en) 1998-10-01 2002-08-13 エラン ファーマ インターナショナル，リミティド Sustained release nanoparticle composition
EP1133280A1 (en) 1998-11-20 2001-09-19 RTP Pharma Inc. Method of preparing stable suspensions of insoluble microparticles
US7026290B1 (en) 1998-12-30 2006-04-11 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosprin
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6057289A (en) 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
GB9912476D0 (en) 1999-05-28 1999-07-28 Novartis Ag Organic compounds
OA12619A (en) * 2001-06-21 2006-06-12 Pfizer Prod Inc Self-emulsifying formulations of cholesteryl estertransfer protein inhibitors.

Also Published As

Publication number Publication date
US7026290B1 (en) 2006-04-11
NZ512599A (en) 2003-10-31
WO2000040219A1 (en) 2000-07-13
JP2002534370A (en) 2002-10-15
AU769429B2 (en) 2004-01-29
EP1154759A1 (en) 2001-11-21
DE69939335D1 (en) 2008-09-25
CA2358448C (en) 2009-02-10
ATE404172T1 (en) 2008-08-15
EP1154759B1 (en) 2008-08-13
AU1796200A (en) 2000-07-24
EP1154759A4 (en) 2005-07-20
AU769429C (en) 2004-10-28
PT1154759E (en) 2008-11-20
CA2358448A1 (en) 2000-07-13
DK1154759T3 (en) 2008-12-08

Similar Documents

Publication Publication Date Title
IL143604A0 (en) Dispersable concentrate for the delivery of cyclosporin
US7799340B2 (en) Pharmaceutical compositions for lipophilic drugs
CA2250970C (en) Cyclosporin emulsions
JP4761093B2 (en) Pharmaceutical composition comprising omega-3 fatty acid oil
ZA973653B (en) Pharmaceutical compositions.
DK1682091T3 (en) COMPOSITIONS OF LIPIDS AND CATIONIC PEPTIDES
FR2710535B1 (en) Composition for pharmaceutical or cosmetic use capable of forming a microemulsion.
KR960021056A (en) Cyclosporine-containing soft capsule composition
KR950007873A (en) Biologics Sustained-Release Pharmaceutical Formulations
KR960016904A (en) Cyclosporine-containing soft capsule composition
WO1994008610A1 (en) Pharmaceutical emulsion compositions
KR970064620A (en) Cyclosporin-containing external-use pharmaceutical composition
AU2003248969A1 (en) Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant
KR970706803A (en) Oral Cyclosporin Formulations (Oral Cyclosporin Formulations)
AU2003260706A1 (en) Oral pharmaceutical compositions comprising cyclosporin
JPH0570793A (en) Granular lipid composition
JPH10330250A (en) Menatetrenone oily formulation
CA2079157A1 (en) Pharmaceutical compositions
JP2001097858A (en) Vitamin a derivative-containing composition
JP2003104827A (en) Cosmetic
JP2003321338A (en) Emulsified cosmetic
JPH10298109A (en) Preservative for emulsion and emulsion
RU99121398A (en) PHARMACEUTICAL COMPOSITIONS
MY118614A (en) Cyclosporin-containing pharmaceutical compositions
KR970061250A (en) Composition of glyclajide-containing soft capsule contents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed